Antiphospholipid, antinuclear, epstein-barr and cytomegalovirus antibodies, and soluble interleukin-2 receptors in depressive patients
- 28 February 1991
- journal article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 21 (2), 133-140
- https://doi.org/10.1016/0165-0327(91)90060-6
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Serum levels of interleukin‐2 receptor and activity of rheumatic diseases characterized by immune system activationArthritis & Rheumatism, 1988
- Cellular immunity and the hypothalamic-pituitary axis in major affective disorder: A preliminary studyPsychiatry Research, 1988
- Chlorpromazine‐induced anticardiolipin antibodies and lupus anticoagulant: Absence of thrombosisAmerican Journal of Hematology, 1988
- Phenothiazine-Associated Lupus Anticoagulant and Thrombotic DiseasePsychosomatics, 1988
- Alterations in immunocompetence during stress, bereavement, and depression: focus on neuroendocrine regulationAmerican Journal of Psychiatry, 1987
- Serum antibodies to Epstein-Barr virus in patients with major depressive disorderAmerican Journal of Psychiatry, 1986
- The lupus anticoagulant. A disease marker in antinuclear antibody negative lupus that is cross‐reactive with autoantibodies to double‐stranded DNAArthritis & Rheumatism, 1985
- The Immune Response Evokes Changes in Brain Noradrenergic NeuronsScience, 1983
- Auto-antibodies in affective disordersProgress in Neuro-Psychopharmacology, 1981
- RAISED CYTOMEGALOVIRUS-ANTIBODY LEVEL IN CEREBROSPINAL FLUID OF SCHIZOPHRENIC PATIENTSThe Lancet, 1980